February 07, 2026 08:13 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Big call from RBI: Repo rate stays at 5.25%, neutral stance continues | RG Kar scam twist: Court issues non-bailable warrant against whistle-blower Akhtar Ali | Court snub for Vijay: Madras HC rejects plea in ₹1.5 crore tax case | ‘We never said no’: Suryakumar Yadav says India ready for Pakistan clash at T20 World Cup | Supreme Court orders Mamata govt to clear pending dues | ‘India is free to buy oil from anyone’: Russia fires back at Trump’s crude deal claim | ‘Justice crying behind closed doors’: Mamata Banerjee slams ECI in Supreme Court, CJI Kant assures solution | Mummy, Papa, sorry: Three sisters jump to death after parents object to online gaming | Supreme Court raps Meta, WhatsApp: ‘Theft of private information, won’t allow its use’ | ‘Completely surrendered’: Congress slams Modi after Trump’s trade deal move
Vaccine dry run
Image Credit: Unsplash

Ahead of Covid-19 vaccine rollout, second dry run to be held on Friday

| @indiablooms | Jan 07, 2021, at 04:18 am

New Delhi/IBNS: A second dry run for the Covid-19 vaccination will be held in all states on Friday, media reports said.

The first large scale dry-run was conducted in all states and UTs on Jan 2 with an objective to test operational feasibility of the use of CO-WIN app, assess the linkage between planning and  implementation as well as to identify challenges before actual implementation.

The second exercise is an attempt to check the best way to vaccinate people against Covid-19 and find out loopholes in logistics and training.

The day-long drive on Friday will again test the operational feasibility of CoWIN application in a field environment.

Short for Covid Vaccine Intelligence Network, CoWIN is a digital platform to roll out and scale up the vaccination drive.

The Centre on Tuesday informed that Covid-19 vaccines will be ready for rollout in 10 days from the emergency use authorisation date based on feedback from the dry run.

Two Covid-19 vaccine candidates-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-on Sunday received the approval of the Drugs Controller General of India (DCGI) for emergency use in India.

The announcement by the Centre came as a relief amid growing fears over the spread of the mutant strain of coronavirus, that was first detected in the UK and is up to 70 per cent more infectious.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.